Imunon, Inc. (IMNN)
$1.59-$0.01 (-0.31%) Today
Latest IMNN Insider Trades
Susan Eylward - OfficerOpen-market sale$4K
Susan Eylward - OfficerSusan Eylward - OfficerSusan Eylward - OfficerSusan Eylward - OfficerSusan Eylward - Officer
Michael H. Tardugno - OfficerImunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective and durable responses across a broad array of human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. The first modality, TheraPlas, is developed for the coding of proteins and cytokines in the treatment of solid tumors. The second modality, PlaCCine, is developed for the coding of viral antigens that can elicit an immunological response. The company's clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 5 | 19,860 | $34K |
| Grant or award | 28 | 246,556 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
46 Form 4 filings on record, the earliest from Oct 8, 2024, newest first. Filing history page 2 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
 James E. Dentzer - Director | Grant or award | Common Stock | 11,148 | $2.20 | $25K | |
| Donald P. Braun - Director | Grant or award | Common Stock | 5,011 | $2.20 | $11K | |
| Frederick J. Fritz - Director | Grant or award | Common Stock | 10,330 | $2.20 | $23K | |
| Stacy Lindborg - Officer | Grant or award | Common Stock | 1,491 | $2.20 | $3K | |
| Stacy Lindborg - Officer | Option exercise | Common Stock | 1,667 | $0.00 | - | |
| Stacy Lindborg - Officer | Option exercise | Restricted Stock | 1,667 | $0.00 | - | |
| Stacy Lindborg - Officer | Grant or award | Stock Option (Right to Buy) | 5,000 | $0.00 | - | |
| James E. Dentzer - Director | Grant or award | Common Stock | 3,318 | $8.00 | $31K | |
| James E. Dentzer - Director | Grant or award | Stock Option (Right to Buy) | 250 | $0.00 | - | |
 Christine A. Pellizzari - Director | Grant or award | Common Stock | 2,248 | $8.00 | $21K | |
| Christine A. Pellizzari - Director | Grant or award | Stock Option (Right to Buy) | 250 | $0.00 | - | |
| Khursheed Anwer - Officer | Grant or award | Stock Option (Right to Buy) | 1,667 | $0.00 | - | |
| Michael H. Tardugno - Officer | Grant or award | Stock Option (Right to Buy) | 1,667 | $0.00 | - | |
| Kimberly Bragg - Officer | Grant or award | Stock Option (Right to Buy) | 667 | $0.00 | - | |
| Donald P. Braun - Director | Grant or award | Common Stock | 2,040 | $8.00 | $19K | |
| Donald P. Braun - Director | Grant or award | Stock Option (Right to Buy) | 250 | $0.00 | - | |
| Susan Eylward - Officer | Grant or award | Stock Option (Right to Buy) | 417 | $0.00 | - | |
| Frederick J. Fritz - Director | Grant or award | Common Stock | 3,161 | $8.00 | $29K | |
| Frederick J. Fritz - Director | Grant or award | Stock Option (Right to Buy) | 250 | $0.00 | - | |
| Michael H. Tardugno - Officer | Grant or award | Stock Option (Right to Buy) | 12,500 | $0.00 | - | |
| Susan Eylward - Officer | Grant or award | Stock Option (Right to Buy) | 50,000 | $0.00 | - |
This is as far as the anonymous view goes. Create a free account for all 46 IMNN filings on record.
Imunon, Inc. (IMNN) had 28 insider filings in the last 90 days, with the most recent on 2026-08-17. The full record for IMNN runs to 46 Form 4 filings, the earliest from 2024-10-08. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of IMNN were filed in the last 90 days.
5 insider sales of IMNN were filed in the last 90 days, totaling $34K.
This page tracks IMNN Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add IMNN to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
